# A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

> **NCT07682506** · PHASE3 · RECRUITING · sponsor: **Minghui Pharmaceutical (Hangzhou) Ltd** · enrollment: 405 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** MH004 1.0% Ointment
- **DRUG:** MH004 Placebo Ointment

## Key facts

- **NCT ID:** NCT07682506
- **Lead sponsor:** Minghui Pharmaceutical (Hangzhou) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2028-02-23
- **Final completion:** 2028-10-04
- **Target enrollment:** 405 (ESTIMATED)
- **Last updated:** 2026-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682506, "A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*